GGrantIndex
Sort

261,768 grants matching gene therapy

ROLE OF RNA SEQUESTRATION IN ACUTE MYELOID LEUKEMIA

$2,398,360
Bruno Di Stefano · Baylor College Of Medicine · R01 · FY2025 · CA

PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM

$2,397,983
Fred Hutchinson Cancer Research Center · P50 · FY2000 · CA

SCOR in Molecular Medicine and Atherosclerosis

$2,397,891
Joseph L Witztum · University Of California, San Diego · P50 · FY2006 · HL

The Cellular Geography of Therapeutic Resistance in Cancer

$2,397,774
Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2021 · CA

Translational Research in Breast Cancer

$2,397,689
Baylor College Of Medicine · P50 · FY2005 · CA

GLO1/Aβ-mediated mitochondrial and synaptic injury in Alzheimer's disease

$2,397,468
Shi Du Yan · Columbia University Health Sciences · RF1 · FY2023 · AG

Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm

$2,397,289
Daniel B Rifkin · New York University School Of Medicine · P01 · FY2021 · HL

Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects

$2,396,962
John Didsbury · T3d Therapeutics, Inc. · R01 · FY2020 · AG

Molecular Diagnostics Core Laboratory

$2,396,812
Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

HIV/AIDS Vaccine and Antibody Development

$2,396,730
John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI

Pharmacogenomic Evaluation of Antihypertensive Responses

$2,396,496
Julie A. Johnson · University Of Florida · U01 · FY2007 · GM

Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment

$2,396,241
Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2023 · DC

Targeted Therapies in Melanoma

$2,395,590
Meenhard Herlyn · Wistar Institute · P01 · FY2012 · CA

Using Genetics For Early Phenotyping & Prevention of Hypertrophic Cardiomyopathy

$2,395,197
Carolyn Y Ho · Brigham And Women'S Hospital · P50 · FY2012 · HL

Targeting hepatitis B virus cccDNA during HBV/HIV co-infection

$2,395,056
Alexander Ploss · Princeton University · R01 · FY2025 · AI

Cellular and Molecular Studies of Bone Marrow Transplant

$2,394,938
James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · CA

Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing

$2,394,473
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2023 · AG

Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders

$2,394,432
Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2013 · HL

Frontotemporal Dementias: Genotypes and Phenotypes

$2,394,324
Virginia M Lee · University Of Pennsylvania · P01 · FY2016 · AG

Immunological Analysis of Brain Cancer

$2,394,103
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts

$2,394,018
Flavio Vincenti · University Of California, San Francisco · U01 · FY2015 · AI

DF/HCC Prostate SPORE

$2,393,890
Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2024 · CA

Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm

$2,393,711
Daniel B Rifkin · New York University School Of Medicine · P01 · FY2022 · HL

Synaptic selectivity for microglial-mediated damage in Alzheimer's Disease

$2,393,130
Stephen M Strittmatter · Yale University · RF1 · FY2021 · AG

DNA Replication, Repair, and Mutagenesis In Eukaryotic And Prokaryotic Cells

$2,392,540
Roger Woodgate · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD